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Abstract
Little is known about long-term associations between the Dietary Approaches to Stop Hypertension (DASH) diet and conventional
cardiovascular (CV)-risk factors as well as novel measures of vascular function. This study aimed to examine whether long-term adherence to
a DASH-type diet in a British birth cohort is associated with conventional CV-risk factors and two vascular function markers, carotid intima–
media thickness (cIMT) and pulse wave velocity (PWV). Data came from 1409 participants of the Medical Research Council (MRC) National
Survey of Health and Development. Dietary intake was assessed at 36, 43, 53 and 60–64 years using 5-d estimated food diaries. The DASH-
type diet score was calculated using the Fung index. Conventional CV-risk factors (blood pressure (BP) and lipids), cIMT in the right and/or
left common carotid artery and PWV was measured when participants were 60–64 years. Associations between the DASH-type diet score and
outcomes were assessed using multiple regression models adjusted for socioeconomic position, BMI, smoking and physical activity.
Participants in higher sex-speciﬁc quintiles (Q) of the long-term DASH-type diet had lower BP (P≤ 0·08), higher HDL-cholesterol (P< 0·001)
and lower TAG (P< 0·001) compared with people in Q1. Participants in Q5 of the long-term DASH-type diet had lower PWV (−0·28 SD; 95% CI
−0·50, −0·07, Ptrend= 0·01) and cIMT (−0·24 SD; 95% CI −0·44, −0·04, Ptrend= 0·02) compared with participants in the Q1. This association was
independent of the conventional CV-risk factors. Greater adherence to a DASH diet over the life course is associated with conventional CV-risk
factors and independently associated with cIMT and PWV.
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CVD remains a signiﬁcant public health problem worldwide
despite reductions in mortality in high-income countries(1).
Many modiﬁable and non-modiﬁable factors have been
implicated in the aetiology of CVD. Diet is one such modiﬁable
factor. The association between diet and CVD has been studied
extensively, but evidence that supports the role of speciﬁc
foods or nutrients remains equivocal. This lack of consistent
evidence is partly due to the complexities of measuring
diet as an exposure. An individual’s diet consists of a variety of
foods which contain an assortment of nutrients and non-
nutrients that can act interactively, synergistically or cumula-
tively to affect the initiation and/or progression of a disease(2).
Examining the effect of overall diet on CVD instead of single
nutrients may capture the collective beneﬁts of this hetero-
geneous exposure.
A number of different diets, foods and nutrients have been
identiﬁed as being cardio-protective, including the Dietary
Approaches to Stop Hypertension (DASH) diet(3). The DASH
Abbreviations: BP, blood pressure; cIMT, carotid intima–media thickness; CV, cardiovascular; DASH, Dietary Approaches to Stop Hypertension; DBP, diastolic
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diet is characterised by high proportions of fruit, vegetables,
low-fat dairy products and whole-grain foods and is low in
saturated fat and reﬁned sugar(4). The DASH diet was designed
for an 8-week trial to compare the effect of consuming the
average US diet v. a diet high in fruit and vegetables or the
DASH diet, on blood pressure (BP)(4). Both diets lowered BP
compared with the average US diet, with people adhering to the
DASH diet experiencing the greatest BP reduction(4).
Observational studies have since shown that adherence to a
DASH-type diet is associated with a lower incidence of stroke,
heart failure and heart disease(5,6).
The most compelling evidence to date for the cardio-
protective mechanism of DASH is through its BP-lowering
effect. In a meta-analysis of seventeen randomised controlled
trials (RCT; n 2561, duration 2–26 weeks), the DASH diet
reduced systolic BP (SBP) by 6·74mmHg (95% CI −8·25, −5·23 )
and diastolic BP (DBP) by 3·54mmHg (95% CI, −4·29, −2·79).
The greatest effect was seen among hypertensive participants
and in studies where the interventions were designed to
restrict energy intake(7). Limiting Na intake increases this
BP-lowering effect of DASH(8). A number of meta-analyses of
RCT have been conducted which examine the role of DASH in
relation to other CVD risk factors. Soltani et al.(9) (ten studies,
n 1291, duration= 8–24 weeks) showed that adults on a DASH
diet lost 1·42 kg (95% CI −2·03, −0·28) more weight on average
compared with controls. Authors of another meta-analysis
(twenty studies, n 1917, duration= 2–24 weeks) observed a
decrease in total cholesterol and LDL-cholesterol, but not
glucose, HDL-cholesterol or TAG. Changes were greatest
among those with higher baseline BP or BMI(10). Given that the
majority of evidence for the cardio-protective role of the DASH
diet comes from trials, its long-term effect on conventional
cardiovascular (CV)-risk factors, such as, BP and lipids remains
unknown.
The role of the DASH diet in novel aetiological CVD
pathways is also under-explored. Vascular and endothelial
dysfunction represent an integrated CVD risk pathway(11).
Dysfunction of the vascular endothelium is characterised by
damage to its barrier function, impaired vasodilator responses,
thrombogenesis and increased expression of adhesion
molecules with leucocytosis. This dysfunction is considered a
key initial event in atherogenesis(12). Carotid intima–media
thickness (cIMT), a non-invasive ultrasound biomarker of early
atherosclerosis(13) and carotid-femoral pulse wave velocity
(PWV), a measure of arterial compliance as well as stiffness(14)
are two complementary measures of vascular function that have
been used to predict CVD risk in the general population. There
is some limited evidence mainly from RCT that the DASH diet
and/or its components can affect these markers of vascular
function(15–18). Examining the association between adherence
to a DASH-type diet and these novel vascular function markers
may provide useful insights into the role of diet in the early
stages of CVD and reveal opportunities for early CVD
prevention.
This study aims to use data from a British birth cohort to
examine whether long-term adherence to a DASH-type diet is
associated with: (1) conventional CV-risk factors; (2) two
markers of vascular function: cIMT and PWV.
Methods
Participants
We used data from participants of the Medical Research Council
(MRC) National Survey of Health and Development (NSHD). The
original NSHD sample consisted of 5362 babies born in 1 week
in March 1946 to married parents in England, Scotland or Wales,
stratiﬁed by social class(19). This sample has been followed up
twenty-four times since birth(20,21). At the 23rd follow-up, eligible
study members (n 2856) were invited to complete a clinical
assessment at one of six clinical research facilities or home
visitation by a nurse when they were 60–64 years. Invitations
were not sent to those who had died (n 778), who were living
abroad (n 570), had previously withdrawn from the study
(n 594), or had been lost to follow-up (n 564). A total of 2229
participants responded of whom 76% (n 1690) attended a clinic
and 24% (n 539) had a home visit. Although this sample was
broadly representative of the national population at a similar age,
individuals attending the clinical assessment had lower adiposity
and lifetime smoking exposure and higher levels of physical
activity compared with the original cohort(22). Information about
participants’ smoking habits at 69 years was used to impute
missing values at 60–64 years as described below. For the main
analyses in this study we included participants who had infor-
mation for at least one of the vascular measures at 60–64 years
(1565 for cIMT and 1257 for PWV) and who had dietary infor-
mation from at least two adult time points (1335 for cIMT and
1081 for PWV). A ﬂow chart of participants included in our
study can be found in the online Supplementary Fig. S1. Ethical
approval was obtained from the Greater Manchester and the
Scotland Research Ethics Committees and participants provided
written and informed consent (Fig. 1).
Dietary Approaches to Stop Hypertension-type diet
Information about dietary intake was collected using 5-d esti-
mated diet diaries when participants were aged 36, 43, 53 and
60–64 years(23–27). All food and drink consumed were coded in
MRC Human Nutrition Research Cambridge using the in-house
programmes, Diet In Data Out and Diet In Nutrients Out.
Nutrient intakes were calculated based on McCance and Wid-
dowson’s The Composition of Foods(28). A total of 2411, 2256,
1772 and 1869 participants at 36, 43, 53 and 60–64 years,
respectively, completed ≥3 d of the diet diaries. When
generating the DASH-type diet in NSHD, we included all
participants with dietary information regardless of whether they
attended the clinical assessment at 60–64 years.
We calculated the DASH score in accordance with previously
published methods by Fung et al.(5). The DASH score was based
on the original studies of the DASH diet focusing on eight
components in particular: high intake of fruits (including pure
fruit juice), vegetables (excluding potatoes), nuts and legumes,
low-fat dairy products, wholegrains and low intake of red and
processed meats, Na and sweetened beverages (including sugar
sweetened cordial and sweetened fruit based drinks)(5). These
components consisted of discrete foods as well as disaggregated
foods(29). Details of what was included in each of these com-
ponents can be found in the online Supplementary Table S1.
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Each individual’s DASH score was calculated for each year using
the following steps: (1) the energy density for each component
was calculated, for example fruit (g)/energy (4184 kJ
(1000kcal))(30); (2) each component was classiﬁed into quintiles
(Q), where fruits, vegetables, nuts and legumes, low-fat dairy
products and wholegrains were assigned 1–5 points in order of
most consumption. Quintiles for red and processed meats, free
sugar and Na were assigned 1–5 points in order of least con-
sumption; (3) the quintiles for each component were summed to
obtain an overall DASH score which could range from 8 to 40;
(4). As the DASH score was higher in women (mean differ-
ence= 2·3; 95% CI 1·9, 2·8), the overall DASH score was grouped
into sex-speciﬁc quintiles (Q1–Q5) for use in regression models.
We calculated a cumulative average of all DASH scores over
the 24–28-year period for each individual who had dietary
information from at least two time points (n 2477). This repre-
sents long-term adherence to the DASH-type diet(31). This
mean, long-term DASH score was also grouped into sex-
speciﬁc quintiles (Q1–Q5).
Cardiovascular risk factors
SBP and DBP were measured twice using a HEM-705 sphyg-
momanometer (Omron) at the 60–64 years clinic visits. The
second reading (or ﬁrst if missing) was used for analysis. Total
cholesterol, HDL, TAG and LDL were also measured in fasting
blood samples as previously described(20,32). Information on
the use of antihypertensive and lipid-lowering drugs was
self-reported at 60–64 years.
Vascular measures at 60–64 years
Vascular measures were obtained by trained research staff
during the clinical assessment only when participants were
60–64 years. PWV was measured using the Vicorder (Skidmore
Medical) by placing a 10-cm wide pressure cuff at the upper right
thigh and 3 cm partial cuff over the right carotid artery. Cuffs
were inﬂated to 65mmHg for 10–15 s. Path length was measured
between the cuffs and deﬁned as the distance between the
suprasternal notch directly to the top of the femoral cuff. PWV
was automatically calculated by an integral algorithm. cIMT was
measured in the left and right common carotid artery using a
high-resolution imaging scanner (Vivid I, GE Healthcare (12MHz
probe)) with a 12MHz probe(33,34). Participants with carotid
plaque, cIMT >1·5mm with abnormal shape and wall texture,
were excluded (n 13)(34). A combined average of left and right
cIMT is used as one outcome. To increase comparability, each
outcome was standardised to a mean of 0 and SD of 1.
Covariates
Socioeconomic position (SEP) at age 53 years (or 43 years if
missing) was grouped into: professional and intermediate;
skilled non-manual; semi-skilled and unskilled manual.
BMI was calculated using the standard formula with infor-
mation from height and weight measured at 60–64 years.
Physical activity in adulthood was self-reported. Participants
were categorised as inactive (reported no participation); mod-
erately active (participated in relevant activity one to four times/
month) or most active (participated in relevant activities ﬁve or
more times/month) using information at 36, 43, 53 and 60–64
years. The overall physical activity score was the sum of
responses at each time point, ranging from 0 to 8(35). Smoking
status at 60–64 years was categorised as never, current or
ex-smoker at 60–64 years (or 53 or 69 years if missing (n 115)).
Statistical analysis
First, a series of regression models determined if long-term
adherence to a DASH-type diet (modelled as sex-speciﬁc
40
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Fig. 1. Dietary Approaches to Stop Hypertension-type diet score per year by sex of the 769 participants with dietary data from all time points.
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quintiles) associated with: antihypertensive medication,
lipid-lowering medication, DBP, SBP, total cholesterol, LDL-
cholesterol, HDL-cholesterol, and TAG at 60–64 years. We used
logistic regression models when antihypertensive or
lipid-lowering medications were the outcomes and linear
regression when HDL was the outcome. We used censored
normal regression when SBP, DBP, TAG, total cholesterol or
LDL-cholesterol were the outcomes. Individuals taking
antihypertensive or lipid-lowering medication were censored at
their observed value. This assumes that the underlying BP or
lipid levels in an individual taking medication is at least as
high as their observed value and aims to reduce bias and a loss
of statistical power(36). TAG were not normally distributed so
log transformed values were used in the model. All models
were adjusted for SEP, BMI, smoking and physical activity. Log
likelihood ratio tests assessed deviation from linearity by
comparing models with the DASH quintiles ﬁtted as a catego-
rical variable to models with DASH quintiles ﬁtted as a con-
tinuous variable.
Second, regression models assessed associations between
long-term adherence to a DASH-type diet and the standardised
vascular function outcomes: cIMT and PWV. Models
were adjusted for SEP, BMI, smoking and physical activity.
Deviation from linearity was tested using log likelihood
ratio tests. Interactions between the DASH-type diet and
sex on the vascular outcomes were also assessed. Models were
re-run separately for individual DASH scores at 36, 43, 53 and
60–64 years, adjusting for the covariates mentioned above. In
order to maximise power, these analyses did not exclude
participants with dietary information available from only one
time point.
Third, models that assessed long-term adherence to a DASH-
type diet and vascular function were additionally adjusted for
CV-risk factors found to be associated with the DASH-type diet
in step one. This step assessed the potential for a mediating role
of CV-risk factors on the relationship between the DASH-type
diet and vascular function.
All analyses were performed using STATA version 14.
Results
A total of 1409 participants (52% women) had at least one
measure of cIMT or PWV at 60–64 years and had dietary
information from at least two time points between 36 and 60–64
years (online Supplementary Fig. S1). These participants were
more physically active, smoked less and had a lower
BMI compared with people attending the clinical assessment
who did not have this dietary and vascular measure information
(n 820).
Mean cIMT and PWV were slightly higher for men
compared with women, whereas DASH scores were higher for
women (Table 1). Mean DASH scores did not change notice-
ably over time (Table 1). Figure one illustrates DASH scores
from each year for the 769 participants who had dietary data at
all time points. The online Supplementary Table S2 summarises
distributions of each DASH component according to quintiles of
the sex-speciﬁc DASH quintiles.
Long-term Dietary Approaches to Stop Hypertension score
and cardiovascular risk factors
Associations between long-term DASH scores and CVD risk
factors was as expected, that is those in the higher quintiles of
the long-term DASH-type diet had a favourable CVD risk factor
proﬁle compared with those in the lowest quintile. However,
there was no evidence of an association for total or LDL-
cholesterol (Table 2). Adjustment for SEP, BMI, smoking and
physical activity attenuated associations, but evidence for a
relationship between a long-term DASH-type diet and SBP,
lipid-lowering medication, HDL-cholesterol and TAG remained
(Table 2). There was also a tendency for lower DBP with
increasing DASH quintiles remaining following adjustment for
covariates (Ptrend= 0·08).
Dietary Approaches to Stop Hypertension score and
vascular function at 60–64 years
Participants in higher quintiles of long-term DASH-type diet had
better vascular function than those in the lowest quintile after
adjustment for SEP (Table 3). The association remained statis-
tically signiﬁcant following adjustment for BMI, smoking and
physical activity. There was no evidence for an interaction
between long-term DASH score and sex (P≥ 0·32) for either
cIMT or PWV. There was no evidence for deviation from a
linear trend between the long-term DASH score and PWV and
cIMT (P≥ 0·50).
Prospective and cross-sectional associations between DASH
scores at each follow-up and PWV were in the same direction
but generally weaker compared with results for long-term
DASH scores (online Supplementary Table S3). The strongest
prospective association between DASH scores and cIMT was at
36 years. This association was bigger in magnitude compared
with long-term DASH scores (online Supplementary Table S3).
Long-term Dietary Approaches to Stop Hypertension score,
vascular function and cardiovascular risk factors at
60–64 years
There was no evidence that CV-risk factors which showed an
association with DASH-type diet in this study (i.e. DBP, SBP,
lipid-lowering medication, HDL-cholesterol and TAG) explain
the association between long-term DASH scores and vascular
function (Table 4).
Discussion
We showed that long-term adherence to a DASH-type diet is
associated with a favourable CV-risk proﬁle in adulthood using
data from a British birth cohort. We also observed a relationship
between long-term adherence to a DASH-type diet and
improved vascular function, which was not explained by the
conventional CV-risk factors.
There is substantial evidence from RCT for the role of the
DASH diet in reducing BP(4,7,8) and our study supports this.
However, the magnitude of the estimated relationship between
long-term adherence to DASH and BP in this longitudinal
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observational study is smaller than estimates from RCT(7). In this
study, we observed SBP to be 4·83mmHg (95% CI −8·35, −1·31)
and DBP to be 1·59mmHg (95% CI 0 −3·49, 0·31) lower among
people in the highest DASH-type diet quintile compared with
the lowest quintile. Results from a meta-analysis of RCT showed
an average reduction which was 6·74mmHg (95% CI −5·23,
−8·25) in SBP and 3·54mmHg (95% CI −4·29, −2·79) in DBP
greater among people consuming a DASH diet compared with
controls(7). This difference in effect size is likely due to the
differences in length of exposure, speciﬁcation of the DASH
diet and study design. To our knowledge, we were the ﬁrst to
demonstrate an association between a DASH-type diet and
other conventional CV-risk factors (i.e. HDL-cholesterol, TAG)
in a longitudinal observational study. This ﬁnding was not fully
supported by a meta-analysis of RCT(10). Differences in study
design, that is RCT lasting 2–24 weeks v. longitudinal observa-
tional study assessing a 24–28-year period, is the likely cause of
this inconsistency.
Our ﬁndings are also the ﬁrst to demonstrate that greater
adherence to a DASH-type diet over a 24–28-year period in
adulthood is associated with a greater vascular function as
measured by the vascular function markers, PWV and cIMT.
There are a limited number of studies investigating the asso-
ciation between a DASH-type diet or its key dietary compo-
nents and PWV. These studies are largely supportive of our
results. Findings from an intervention study demonstrated a
reduction in arterial stiffness among nineteen normotensive
participants consuming a low-Na DASH diet compared with the
consumption of a diet low in fruit and vegetables over a 3-week
period(15). Authors from another RCT including 144 overweight
and obese participants (forty-nine participants consuming a
DASH diet and enrolled in a weight management programme;
forty-six consuming standard DASH diet; forty-nine on a control
diet), found that people in the two DASH diet interventions had
lower PWV compared with controls(16). To our knowledge,
there is no previous observational evidence for the association
between a DASH diet and PWV. A review has highlighted that a
number of DASH components, including high fruit and vege-
table and dairy product composition have been associated with
lower PWV providing further support for our ﬁndings(17).
Table 1. Descriptives of participants with at least one vascular measure and dietary information from more than one time point (n 1409)
(Numbers and percentages; mean values and standard deviations)
Men (n 673) Women (n 736)
n* % Mean SD n* % Mean SD
Socioeconomic status at 53 years
(or 43 years if missing)
Professional and managerial 429 64·3 323 45·2
Skilled non-manual 67 10·0 260 36·4
Skilled manual 124 18·6 43 6·1
Semi-skilled and unskilled 47 7·1 89 12·5
BMI at 60–64 years (kg/m2) 673 27·6 3·8 736 27·3 5·0
Smoking status at 60–64 years (or 53/69 years if missing) 543 10·8 15·3 585 7·7 13·2
Current 61 9·2 63 8·6
Ex-smoker 409 61·5 394 53·3
Never smoker 195 29·3 279 38·1
Self-reported physical activity since 1982
Inactive at all ages 71 10·6 96 13·0
Active at least once/month 551 81·9 605 82·2
Active more than once/month 51 7·6 35 4·8
Antihypertensive medication at 60–64 years
No 463 71·0 547 75·6
Yes 189 29·0 177 24·5
Lipid-lowering medication at 60–64 years
No 501 74·4 623 84·7
Yes 172 25·6 113 15·4
Vascular phenotype at 60–64 years
Systolic blood pressure (mmHg) 672 138·8 18·1 732 132·1 7·4
Diastolic blood pressure (mmHg) 673 78·9 10·0 732 75·5 9·4
Total cholesterol (mmol/l) 648 5·3 1·1 697 6·1 1·2
LDL-cholesterol (mmol/l) 627 3·3 0·9 684 3·8 1·0
HDL-cholesterol (mmol/l) 648 1·4 0·3 697 1·8 0·4
TAG (mmol/l) 632 1·4 0·9 686 1·1 0·6
Carotid intima–media thickness (mm) 639 0·71 0·15 696 0·67 0·11
Pulse wave velocity (m/s) 501 8·31 1·41 580 8·03 1·57
DASH-type diet score
Long-term DASH score † 673 23·5 3·9 736 25·8 3·9
Mean DASH score at 36 years 554 23·4 4·7 615 25·0 5·1
Mean DASH score at 43 years 572 23·8 4·8 628 26·2 4·8
Mean DASH score at 53 years 478 23·5 5·1 575 26·4 4·9
Mean DASH score at 60–64 years 632 23·7 5·1 700 25·9 5·1
DASH, Dietary Approaches to Stop Hypertension.
* Missing values not presented.
† Average from 36, 43, 53 and 60–64 years in individuals with ≥2 d of dietary information.
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Table 2. Association between long-term Dietary Approaches to Stop Hypertension (DASH) scores (sex-specific quintiles) and classic cardiovascular risk factors* unadjusted
(Coefficients and 95% confidence intervals)
DASH Q2 DASH Q3 DASH Q4 DASH Q5
n DASH Q1 Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI Ptrend†
Unadjusted
Antihypertensive medication‡ 1841 Ref. 0·97 0·65, 1·28 0·68 0·36, 1·00 0·68 0·36, 1·00 0·56 0·23, 0·89 <0·001
Diastolic blood pressure§ 1825 Ref. −0·35 −2·21, 1·51 −1·13 −2·93, 0·67 −1·78 −3·57, 0·02 −3·09 −4·89, −1·30 <0·001
Systolic blood pressure§ 1824 Ref. −1·98 −5·40, 1·45 −4·60 −7·93, −1·28 −5·39 −8·70, −2·08 −7·70 −11·00, −4·40 <0·001
Lipid-lowering medication‡ 1883 Ref. 0·93 0·60, 1·25 0·62 0·28, 0·96 0·63 0·29, 0·97 0·45 0·08, 0·81 <0·001
Total cholesterol§ 1746 Ref. −0·07 −0·25, 0·12 −0·02 −0·20, 0·15 −0·09 −0·26, 0·09 −0·15 −0·32, 0·03 0·10
LDL-cholesterol§ 1670 Ref. −0·08 −0·24, 0·08 −0·02 −0·18, 0·13 −0·06 −0·21, 0·10 −0·07 −0·22, 0·08 0·50
HDL-cholesterol 1746 Ref. 0·05 −0·01, 0·12 0·10 0·04, 0·17 0·11 0·04, 0·17 0·15 0·08, 0·21 <0·001
ln TAG§ 1679 Ref. −7·27 −16·56, 2·02 −24·51 −33·50, −15·52 −25·73 −34·77, −16·69 −41·35 −50·30, −32·40 <0·001
Adjusted for SEP, BMI, smoking and physical activity
Antihypertensive medication‡ 1774 Ref. 0·98 0·64, 1·32 0·73 0·39, 1·08 0·82 0·48, 1·17 0·78 0·41, 1·15 0·12
Diastolic blood pressure§ 1759 Ref. −0·35 −2·19, 1·50 −0·60 −2·41, 1·21 −0·97 −2·80, 0·86 −1·59 −3·49, 0·31 0·08
Systolic blood pressure§ 1758 Ref. −1·93 −5·35, 1·49 −3·45 −6·81, −0·08 −3·62 −7·01, −0·23 −4·83 −8·35, −1·31 0·01
Lipid-lowering medication‡ 1813 Ref. 1·01 0·66, 1·36 0·68 0·32, 1·05 0·76 0·39, 1·12 0·61 0·21, 1·02 0·01
Total cholesterol§ 1687 Ref. −0·13 −0·32, 0·06 −0·07 −0·25, 0·12 −0·11 −0·30, 0·08 −0·16 −0·35, 0·04 0·19
LDL-cholesterol§ 1617 Ref. −0·13 −0·30, 0·04 −0·05 −0·22, 0·11 −0·07 −0·23, 0·10 −0·06 −0·23, 0·11 0·83
HDL-cholesterol 1687 Ref. 0·03 −0·03, 0·09 0·05 −0·01, 0·11 0·04 −0·03, 0·10 0·05 −0·02, 0·11 <0·001
ln TAG§ 1626 Ref. −2·89 −11·88, 6·09 −13·84 −22·64, −5·04 −13·35 −22·31, −4·39 −22·59 −31·85, −13·33 <0·001
Q, sex-specific quintile; Ref., referent values.
* N’s not restricted to those with carotid intima–media thickness or pulse wave velocity measures.
† Linear trend test, that is DASH quintiles fitted as continuous exposure in regression model. No evidence for deviation from linear tend using log likelihood ratio test, that is testing DASH quintiles fitted as continuous exposure v. DASH
quintiles fitted as categorical exposure, P≥0·17 for all models.
‡ Logistic regression, OR presented.
§ Censored regression to account for medication use.
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Compared with PWV, we observed a slightly weaker associa-
tion between the DASH-type diet and cIMT, an early marker of
atherosclerosis. In 2014 Petersen et al.(18) conducted a review of
the association between cIMT and individual dietary compo-
nents and dietary patterns . Although they found observational
evidence for an association between higher fruit and whole-
grain consumption, lower saturated fat consumption (all
components of a DASH-type diet) and lower cIMT, they
emphasised that the evidence is currently weak(18).
PWV has been shown to predict CVD events beyond
conventional risk factors such as those measured by the
Framingham risk score, including BP(37–39). Although a single
measure of cIMT has been shown to predict CVD, it has been
shown to have no predictive value beyond conventional
CV-risk factors(13,40). We observed that the relationship between
the DASH-type diet and both measures of vascular function was
not explained by conventional CV-risk factors (SBP, DBP, lipid-
lowering medication, HDL-cholesterol and TAG) and therefore
associations are not likely to be acting through these mechan-
isms. There are novel mechanisms, for example inﬂammation
and oxidative stress that have also been implicated in the
relationship between a DASH-type diet and CVD(5,41–43) which
may explain the relationship between the DASH-type diet and
vascular function.
The longitudinal design of NSHD allowed us to carry out
secondary analysis to examine the potential for sensitive
Table 3. Long-term Dietary Approaches to Stop Hypertension (DASH) score and vascular function
(Coefficients and 95% confidence intervals)
Standardised carotid intima–media thickness* Standardised pulse wave velocity†
Coefficient 95% CI Coefficient 95% CI
DASH score sex-specific quintiles (Q)
Model 1||
Q1 Ref Ref Ref Ref
Q2 −0·08 −0·28, 0·12 −0·13 −0·35, 0·09
Q3 −0·15 −0·34, 0·04 −0·07 −0·28, 0·14
Q4 −0·18 0·37, 0·01 −0·18 −0·39, 0·02
Q5 −0·35 −0·54, −0·16 −0·30 −0·51, −0·10
Ptrend‡ = <0·001 Ptrend‡=0·003
Pdeviation from trend§=0·72 Pdeviation from trend§=0·52
Model 2||
Q1 Ref. Ref. Ref. Ref.
Q2 −0·06 −0·26, 0·14 −0·13 −0·35, 0·09
Q3 −0·10 −0·29, 0·09 −0·06 −0·27, 0·15
Q4 −0·10 −0·29, 0·09 −0·17 −0·38, 0·04
Q5 −0·24 −0·44, −0·04 −0·28 −0·50, −0·07
Ptrend‡ =0·02 Ptrend‡ =0·01
Pdeviation from trend§=0·74 Pdeviation from trend§=0·50
Ref., referent values.
* cIMT model 1: n 1309 model 2: n 1298.
† PWV model 1: n 1061 model 2: n 1051.
‡ Linear trend test, that is DASH quintiles fitted as continuous exposure in regression model.
§ Log likelihood ratio test, that is testing DASH quintiles fitted as continuous exposure v. DASH quintiles fitted as categorical exposure.
|| Model 1 adjusted for socioeconomic position; model 2 additionally adjusted for BMI, smoking and physical activity.
Table 4. Long-term Dietary Approaches to Stop Hypertension (DASH) score and vascular function adjusted for
conventional cardiovascular risk factors||
(Coefficients and 95% confidence intervals)
Standardised carotid intima–media
thickness*
Standardised pulse wave
velocity†
DASH score sex-specific quintiles (Q) Coefficient 95% CI Coefficient 95% CI
Q1 Ref. Ref. Ref. Ref.
Q2 −0·04 −0·24, 0·16 −0·14 −0·35, 0·08
Q3 −0·08 −0·27, 0·11 −0·07 −0·27, 0·13
Q4 −0·07 −0·26, 0·13 −0·13 −0·33, 0·07
Q5 −0·24 −0·44, −0·04 −0·24 −0·45, −0·04
Ptrend‡=0·02 Ptrend‡= 0·03
Pdeviation from trend§=0·52 Pdeviation from trend§=0·54
* cIMT: n 1220.
† PWV: n 980.
‡ Linear trend test, that is DASH quintiles fitted as continuous exposure in regression model.
§ Log likelihood ratio test, that is testing DASH quintiles fitted as continuous exposure v. DASH quintiles fitted as categorical exposure.
|| Adjusted for socioeconomic position, BMI, smoking and physical activity, diastolic blood pressure, systolic blood pressure, lipid-lowering
medication, HDL-cholesterol, TAG.
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periods in adulthood in which the consumption of a DASH-type
diet might be most beneﬁcial for vascular function. The
association between the DASH diet and PWV did not differ
greatly over time. However, the association between greater
adherence to a DASH diet at 36 and 43 years and cIMT was
stronger than any other time point. This suggests that
consuming a DASH-type diet from earlier-adulthood may be
particularly important for cIMT.
The major strengths of this study were the use of a nationally
representative birth cohort of the white British population born
in the early post World War II period(19,22) and detailed repe-
ated measures of dietary intake as assessed by diet diaries over
a 24–28-year period. Our sample for this study had a slightly
healthier lifestyle (i.e. smoked less, exercised more and had a
lower BMI) compared with the remaining study participants. As
this was an observational study, exact replication of the original
DASH diet(4) was not possible. However, we used the Fung
DASH index(5) which has been shown to perform equally well
as other indices(44). Although we did not observe major changes
in adherence to the DASH-type diet over time, a previous study
demonstrated that participants of NSHD have healthier diets the
older they become(26). Cautious interpretation of study ﬁndings
are required since calculation of the DASH-type diet in this
study is relative to this speciﬁc study sample. For example, if the
majority of the study sample did not eat in accordance with the
DASH diet, even those in the highest quintile would have low
adherence to the DASH diet, which may have weakened
observed associations. Miller and colleagues published stan-
dards for maximum scores for deﬁning a DASH-type diet using
different DASH indices, including the Fung index(44). The
participants in the highest DASH quintile in our study were not
quite meeting these standards(44). For example, participants
in the top quintile in our study consumed approximately 3
servings of fruit/d, 2·6 servings of vegetables/d (one portion is
equivalent to 80 g) and 3 servings of wholegrains/d (one
portion is equivalent to 16 g) per 8368 kJ (2000 kcal). The
maximum standard servings/d based on 8368 kJ (2000 kcal) as
outlined by Miller are;≥4 servings of fruit/d, ≥3 vegetables/d
and ≥4 servings of wholegrains/d.
In conclusion, we found observational evidence for an
association between adherence to a DASH-type diet over an
approximately 30-year period and better conventional CV-risk
factors. We also demonstrated an association between long-
term adherence to a DASH-type diet and two vascular function
markers, cIMT and PWV, at 60–64 years which was not
explained by the conventional risk factors. This study provides
further evidence for the beneﬁcial role of a DASH-type diet in
CVD risk reduction; however replication in other longitudinal
observational cohorts is required.
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